| For: | de Mello AJ, Moretti M, Rodrigues ALS. SARS-CoV-2 consequences for mental health: Neuroinflammatory pathways linking COVID-19 to anxiety and depression. World J Psychiatry 2022; 12(7): 874-883 [PMID: 36051596 DOI: 10.5498/wjp.v12.i7.874] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3206/full/v12/i7/874.htm |
| Number | Citing Articles |
| 1 |
Haoyu Wang, Siyu Yang, Jiapei Dai, Fang Zheng, Yi Luo, Jiachen Zhao, E. Du, Ke Lei, Jiawen Lei, Jinpeng Liu, Yifan Xiao, Huoying Chen, Yan Sun. IL-33/ST2 deficiency induces depression-like behaviors through neuroinflammation in the medial prefrontal cortex and hippocampus. Neurochemistry International 2026; 196 doi: 10.1016/j.neuint.2026.106165
|
| 2 |
Nevzad Denerel, Onur Yüksel Öçal. The effect of the COVID-19 pandemic on the mental status of health workers at sports clubs. Turkish Journal of Sports Medicine 2023; 58(1) doi: 10.47447/tjsm.0736
|
| 3 |
Glorister A. Altê, Ana Lúcia S. Rodrigues. Exploring the Molecular Targets for the Antidepressant and Antisuicidal Effects of Ketamine Enantiomers by Using Network Pharmacology and Molecular Docking. Pharmaceuticals 2023; 16(7) doi: 10.3390/ph16071013
|
| 4 |
Aminah I. Fayyaz, Yuchuan Ding. Mental stress, meditation, and yoga in cardiovascular and cerebrovascular diseases. Brain Circulation 2023; 9(1) doi: 10.4103/bc.bc_66_22
|
| 5 |
Faezeh Sadat Hosseini Kakhki, Amir Asghari, Zahra Bardaghi, Akbar Anaeigoudari, Farimah Beheshti, Hossein Salmani, Mahmoud Hosseini. The Antidiabetic Drug Metformin Attenuated Depressive and Anxiety-like Behaviors and Oxidative Stress in the Brain in a Rodent Model of Inflammation Induced by Lipopolysaccharide in Male Rats. Endocrine, Metabolic & Immune Disorders - Drug Targets 2024; 24(13) doi: 10.2174/0118715303275039231228065050
|
| 6 |
Beenish Asrar, Nouman Ali, Imran Ali, Muhammad Naveed. In silico investigation of ketamine and methylphenidate drug-drug conjugate for MDD and ADHD treatment using MD simulations and MMGBSA. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-024-82302-0
|
| 7 |
German Josuet Lapo-Talledo, Jorge Andrés Talledo-Delgado, Diego Portalanza, Ana Lúcia S. Rodrigues, Aline Siteneski. Suicide rates in Ecuador: A nationwide study from 2011 until 2020. Journal of Affective Disorders 2023; 320 doi: 10.1016/j.jad.2022.09.167
|
| 8 |
Sheila Lopez‐Romeo, Susana Subira‐Alvarez, Andrea Miranda‐Mendizabal, Jorge Piqueras‐Marques, Raquel Leal‐Pujol, Silvia Recoder, Esther Calbo, Marc Casajuana‐Closas, Carlos G. Forero, Pere Castellvi. Having any mental health condition before the COVID‐19 pandemic as a risk factor of COVID‐19 contagion during the first year of pandemic: A Spanish adult cohort. Stress and Health 2024; 40(5) doi: 10.1002/smi.3446
|
| 9 |
Bruna R. Kouba, Glorister A. Altê, Ana Lúcia S. Rodrigues. Putative Pharmacological Depression and Anxiety-Related Targets of Calcitriol Explored by Network Pharmacology and Molecular Docking. Pharmaceuticals 2024; 17(7) doi: 10.3390/ph17070893
|
| 10 |
Melissa Ribeiro de Araújo, Michel Haddad, Luiz Henrique Junqueira Dieckmann, Jair de Jesus Mari. Comorbidity between Mental and Physical Disorders. 2025; doi: 10.1007/978-3-031-81802-8_1
|
| 11 |
Qianqian Cao, Ning Zhang, Cuibo Leng, Shoushi Wang, Jun Ma. Emerging Viral Infections (ZIKV, SARS‐CoV‐2, and MPXV) and Depression: Ketamine and (S, R)‐Ketamine as Promising Antidepressants. Reviews in Medical Virology 2025; 35(3) doi: 10.1002/rmv.70036
|
| 12 |
Yoshihiro Noda, Akiko Sato, Misaki Shichi, Ayano Sato, Kyoshiro Fujii, Mio Iwasa, Yasuhiro Nagano, Ryosuke Kitahata, Ryota Osawa. Real world research on transcranial magnetic stimulation treatment strategies for neuropsychiatric symptoms with long-COVID in Japan. Asian Journal of Psychiatry 2023; 81 doi: 10.1016/j.ajp.2022.103438
|
| 13 |
Eder Cáceres, Afshin A. Divani, Andre Emilio Viñan-Garces, Juan Olivella-Gomez, Alejandro Quintero-Altare, Sebastián Pérez, Luis F. Reyes, Nicholas Sasso, Jose Biller. Tackling persistent neurological symptoms in patients following acute COVID-19 infection: an update of the literature. Expert Review of Neurotherapeutics 2025; 25(1) doi: 10.1080/14737175.2024.2440543
|
| 14 |
|
| 15 |
Javier Calleja-Conde, Víctor Echeverry-Alzate, Sara Sánchez-Diez, Elena Giné, Kora-Mareen Bühler. Severe alcohol use and COVID-19: implications for physical and mental health. Frontiers in Psychiatry 2025; 16 doi: 10.3389/fpsyt.2025.1640207
|
| 16 |
Milagros Rojas. Advances in Psychopharmacology, Psychoneuroimmunology and
Societal-based Analyses. Current Psychiatry Research and Reviews 2023; 19(2) doi: 10.2174/266608221902230223161336
|
| 17 |
Abhinav Bassi, Niveditha Devasenapathy, Shani S. Thankachen, Arpita Ghosh, Aman Rastogi, Ritika Khan, Bijini Bahuleyan, Balaji Gummidi, Aneesh Basheer, Thekkumkara Prabhakaran Sreelal, Ashfak Bangi, Yasmeen Shaikh, Dibakar Sahu, Vinay Rathore, Ashish Bhalla, Samita Samita, Merlin Blessan, T. S. Dipu, Manish Jain, Abhishek Mukundbhai Prajapati, Narendra Kuber Bodhey, Vivekanand Jha. Effectiveness of Colchicine for the Treatment of Long COVID. JAMA Internal Medicine 2025; 185(12) doi: 10.1001/jamainternmed.2025.5408
|
| 18 |
Homa Seyedmirzaei, Mahsa Faramarzpour, Amene Saghazadeh, Antônio L. Teixeira, Nima Rezaei. Post-COVID-19 depression and serum interleukin 6 levels: A systematic review and meta-analysis of COVID-19 convalescents with and without depression. The World Journal of Biological Psychiatry 2023; 24(9) doi: 10.1080/15622975.2023.2242928
|
| 19 |
Wenyi Xiao, Jiao Wang, Jianhui Wang, Lu Han, Donghui Wei, Wenxia Zhou, Ning Jiang. LW‐AFC Protects Against Neurological and Neuropsychiatric Effects of SARS‐CoV‐2 Spike Protein in Mice. Basic & Clinical Pharmacology & Toxicology 2025; 137(2) doi: 10.1111/bcpt.70085
|
| 20 |
Doaa Ibrahim, Shaymaa Mohammed Arafa, Eman Mostafa Moazen, Fatima Gaber Yehia, Ahmed Mohamed Khalifa, Sara Sallam, Eman Ali. Relation Between Monocyte-to-lymphocyte Ratio and Depressive
Symptoms in Patients with Non-severe COVID-19 Infection. Current Psychiatry Research and Reviews 2024; 20(4) doi: 10.2174/0126660822257804231026054939
|
| 21 |
German Josuet Lapo-Talledo, Karime Montes-Escobar, Ana Lúcia S. Rodrigues, Aline Siteneski. Hospitalizations for depressive disorders in Ecuador: An eight-year nationwide analysis of trends and demographic insights. Journal of Affective Disorders 2025; 374 doi: 10.1016/j.jad.2025.01.074
|
| 22 |
Jennifer M. Loftis, Evan Firsick, Kate Shirley, James L. Adkins, Anh Le-Cook, Emily Sano, Rebekah Hudson, Jonathan Moorman. Inflammatory and mental health sequelae of COVID-19. Comprehensive Psychoneuroendocrinology 2023; 15 doi: 10.1016/j.cpnec.2023.100186
|
| 23 |
Hymie Anisman, Shawn Hayley, Alexander Kusnecov. The Immune System. 2025; doi: 10.1016/B978-0-443-23565-8.00007-7
|
| 24 |
Yi Zhou, Chunhua Yang, Jing Zhou, Qiyao Zhang, Xingling Sui, Hongyu Dong, Haidong Zhang, Yue Wang. Identifying key biomarkers and therapeutic candidates for post-COVID-19 depression through integrated omics and bioinformatics approaches. Translational Neuroscience 2024; 15(1) doi: 10.1515/tnsci-2022-0360
|
| 25 |
Sergey Yu Tereshchenko. Neurobiological risk factors for problematic social media use as a specific form of Internet addiction: A narrative review. World Journal of Psychiatry 2023; 13(5): 160-173 doi: 10.5498/wjp.v13.i5.160
Abstract(1039) |
Core Tip(1428) |
Full Article(HTML)(11226)
|
Full Article (PDF)-1034K(607)
|
Full Article with Cover (PDF)-1241K(395)
|
Full Article (Word)-348K(63)
|
Full Article (XML)-235K(150)
|
Audio-681K(219)
|
Peer-Review Report-243K(161)
|
Answering Reviewers-582K(178)
|
Times Cited (37)
|
Total Visits (13249)
|
Open
|
| 26 |
Ancha Baranova, Yi Zhao, Hongbao Cao, Fuquan Zhang. Causal associations between major depressive disorder and COVID‐19. General Psychiatry 2023; 36(2) doi: 10.1136/gpsych-2022-101006
|